SCHEMBL4489542

SCHEMBL4489542

CN1CCCN(CC(=O)N(C)c2ccc(NC(=C3C(=O)Nc4cc(C#N)ccc43)c3ccccc3)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.43
PDGFRB P09619 6/20 0.38
FGFR1 P11362 6/20 0.38
KDR P35968 6/20 0.38
PDGFRA P16234 2/20 0.38
FLT1 P17948 2/20 0.38
FGFR2 P21802 2/20 0.38
FGFR4 P22455 2/20 0.38
FGFR3 P22607 2/20 0.38
FLT4 P35916 2/20 0.38
ABL1 P00519 1/20 0.38
NTRK1 P04629 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
KIT P10721 1/20 0.38
NTRK3 Q16288 1/20 0.38
MELK Q14680 9/20 0.38
CHEK1 O14757 3/20 0.38
PRKAB2 O43741 3/20 0.38
NUAK1 O60285 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4489538 1.00 AAK1 (0.43) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4490171 0.97 AAK1 (0.45) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4490169 0.97 AAK1 (0.45) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4482554 0.91 AAK1 (0.39) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4482559 0.91 AAK1 (0.39) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4481634 0.90 AAK1 (0.41) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4481631 0.90 AAK1 (0.41) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4492354 0.89 AAK1 (0.44) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4498313 0.89 MELK (0.46) AAK1PDGFRBFGFR1KDRPDGFRA
SCHEMBL4498314 0.89 MELK (0.46) AAK1PDGFRBFGFR1KDRPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR AAK1 1080/4885PDGFRB 105/4885FGFR1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.